INTRODUCTION
Cardiolipin (CL) and phosphatidylglycerol (PG) are important structural and functional phospholipids in eukaryotic and prokaryotic cells (for reviews, see [1] [2] [3] [4] [5] ). PG is synthesized via the Kennedy [or CDP-1,2-diacyl-sn-glycerol (CDP-DG)] pathway in mammalian tissues [6] . In this pathway, phosphatidic acid (PA) is charged to CDP-DG in the presence of CTP in a reaction catalysed by PA : CTP cytidylyltransferase (EC 2.7.7.41). In the second or committed step of the pathway, CDP-DG in the presence of sn-glycerol 3-phosphate is converted into phosphatidylglycerolphosphate (PGP) in a reaction catalysed by PGP synthase (EC 2.7.8.5). In the third step of the pathway, the PGP formed is rapidly converted into PG in a reaction catalysed by PGP phosphatase (EC 3. 1.3.27) . In most tissues examined, this enzymic activity is high compared with that of PGP synthase, and this is why PGP does not accumulate in mammalian tissues. Finally, PG condenses with another molecule of CDP-DG to form CL in a reaction catalysed by CL synthase [7] .
In the past few years, ceramides have been identified as important metabolites that are produced from the hydrolysis of sphingomyelin (SM) in many different cells (for reviews, see [8, 9] ). For example, tumour necrosis factor α (TNFα), vitamin D $ and γ-interferon all promote the hydrolysis of SM to ceramide and cardiolipin biosynthesis and on phosphatidylglycerolphosphate synthase activity were additive. Phosphatidylglycerol biosynthesis from sn-["%C]glycerol 3-phosphate in permeabilized H9c2 cells was stimulated by preincubation with N-acetylsphingosine, and this was attenuated by okadaic acid. N-Acetylsphingosine treatment of cells elevated mitochondrial phospholipase A # activity. Since the pool sizes of phosphatidylglycerol and cardiolipin were unaltered in these cells, the observed increase in phosphatidylglycerolphosphate synthase activity may be a compensatory mechanism for the N-acetylsphingosine-mediated elevation of mitochondrial phospholipase A # activity. Finally, addition of tumour necrosis factor α to H9c2 cells resulted in an elevation of both phosphatidylglycerolphosphate synthase and phospholipase A # activities. The results suggest that phosphatidylglycerol and cardiolipin metabolism in H9c2 cells may be regulated by intracellular ceramide signalling.
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in HL-60 human leukaemia cells [10] [11] [12] . More recently, ceramides generated from this sphingomyelin cycle of signal transduction have been shown to be involved in the regulation of cellular growth, differentiation and apoptosis (for reviews, see [8, 13, 14] ). Short-chain cell-permeant ceramides [N-acetylsphingosine (C # -Cer) and N-hexanoylsphingosine (C ' -Cer)] have been shown to stimulate both protein phosphatase and protein kinase activities [15, 16] . CL is important for proper functioning of the mitochondrial respiratory chain in Chinese hamster ovary cells [17] , and alterations in CL during dexamethasone-induced apoptosis in thymocytes is well documented [18] [19] [20] .
Since the mitochondrial respiratory chain and apoptosis are both modulated by ceramides [21, 22] , it is possible that CL metabolism may be regulated by ceramide signalling. In the present study, we took advantage of the use of short-chain cellpermeant ceramides to examine whether PG and CL biosynthesis is regulated by short-chain ceramides and ceramide signalling. Our surprising results demonstrate that addition of C # -Cer to H9c2 cells dramatically stimulates PG and CL biosynthesis and that the mechanism appears to be an increase in mitochondrial PGP synthase activity. We show that the signalling action of C # -Cer may be mediated through a ceramide-activated protein phosphatase(s) which is inhibited by okadaic acid and calyculin A. We further show that the pool sizes of PG and CL are unaltered in these cells and that C # -Cer stimulates mitochondrial phospholipase A # (PLA # ) activity in H9c2 cells. A preliminary report of this study was previously published in abstract form [23] . [1,3- Rat myoblastic H9c2 cells were obtained from the American Type Culture Collection. They were cultured in Dulbecco's modified Eagle's medium supplemented with 10 % (v\v) heatinactivated newborn calf serum, 100 units\ml penicillin G, 10 g\ml streptomycin and 0.25 g\ml amphotericin B. Cell cultures were maintained at 37 mC, saturated with humidified air\5 % CO # . Each dish of cells was subcultured at a 1 : 5 ratio and confluency was usually obtained after 4 days of incubation. In all experiments, cells at confluence were made quiescent by incubation in a serum-free medium for 12 h (overnight) prior to addition of chemicals or labelling. All cell incubation procedures were performed at 37 mC. Cell viability was assessed by Trypan Blue exclusion and protein concentration. Treatment of cells with okadaic acid, calyculin A or CPT-cAMP for up to 2 h, or with C # -Cer, C ' -Cer, sphingosine, SMase or TNFα for up to 4 h, did not affect Trypan Blue exclusion or protein concentration when compared with controls.
EXPERIMENTAL

Materials
Treatment of cells with C 2 -Cer, C 6 -Cer, sphingosine, SMase, okadaic acid, calyculin A or TNFα, and cell labelling studies C # -Cer, C ' -Cer and sphingosine were dissolved in ethanol to obtain stock solutions (100i). SMase was dissolved in PBS to obtain a stock of 25 units\ml. Okadaic acid and calyculin A were dissolved in DMSO. CPT-cAMP was dissolved in Dulbecco's modified Eagle's medium, and TNFα was dissolved in PBS. Aliquots of the stock solution were added to quiescent cells maintained in serum-free Dulbecco's modified Eagle's medium. The final concentration of ethanol in the medium was 1 % (v\v) or less, and that of DMSO was 0.25 % (v\v) or less. H9c2 cells in 60 mm-diam. Petri dishes were incubated with 1 ml of medium containing 0.1 µM okadaic acid, 0.1 µM calyculin A or 0.5 mM CPT-cAMP for 2 h. The medium was removed and the cells were washed twice with 3 ml of fresh medium. The cells were then incubated with 2 ml of medium containing [1,3- For cell permeabilization experiments, H9c2 cells were preincubated in the absence or presence of 30 µM C # -Cer for 4 h as described above. The cells were then permeabilized with saponin and incubated for up to 60 min with 0.1 mM ["%C]glycerol 3-phosphate (0.5 µCi\dish) and 0.5 mM CDP-DG exactly as described in [25] . The radioactivity incorporated into PG was then determined as described [25] . In some experiments, H9c2 cells were incubated in the presence of 0.5 mM CPT-cAMP or 0.1 µM okadaic acid for 1 h, followed by incubation with 30 µM C # -Cer for 4 h, and then were permeabilized with saponin and incubated as described above.
Harvesting of H9c2 cells, extraction and analysis of lipid
Cells were washed with 3 ml of ice-cold PBS. Then 2 ml of methanol\water (1 : 1, v\v) was added to the dish and the cells were harvested with a rubber policeman into screw-cap tubes. The suspension was vortexed twice and a 25 µl aliquot was taken for the determination of protein by the method of Lowry et al. [26] . Lipids were extracted by the method of Folch et al. [27] . The organic phase was dried under nitrogen and resuspended in 100 µl of chloroform\methanol (2 : 1, v\v). An aliquot of the lipid suspension was placed on to a TLC plate and phospholipids were separated in two dimensions as described [28] . The TLC plates were prepared by spraying them lightly with 0.4 M boric acid, blotting dry the excess and then air-drying the plates overnight. PG and CL standards were placed on the plate before chromatography, except when lipid phosphorus analysis was performed. The lipids were visualized with iodine vapour, removed and placed into scintillation vials. A 5 ml portion of Ecolite + scintillant was added and the radioactivity was determined after a 24 h period. In some experiments the silica gel was removed for the determination of phospholipid phosphorus by the method of Rouser et al. [29] .
Preparation of the H9c2 mitochondrial fraction
All isolation procedures were performed at 4 mC. H9c2 cells in 100 mm-diam. Petri dishes were incubated with 3 ml of medium in the absence or presence of 30 µM C # -Cer for 4 h. In other experiments, H9c2 cells were incubated with 2 ml of medium containing 0.1 µM okadaic acid, 0.1 µM calyculin A or 0.5 mM CPT-cAMP for 2 h, the medium was removed and the cells were washed twice with 5 ml of fresh medium and then incubated with 3 ml of medium in the absence or presence of 30 µM C # -Cer for 4 h. The cells were harvested into glass tubes with 4 ml of ice-cold PBS using a rubber policeman. These cells were centrifuged at 1000 g for 5 min. The PBS was removed and a 10 % (w\v) homogenate was prepared in 0.25 M sucrose, 10 mM Tris\HCl, pH 7.4, 0.145 M NaCl and 1 mM EDTA using 40 strokes of a tight-fitting Dounce A homogenizer. The homogenate was centrifuged at 1000 g (Sorvall RC-5 centrifuge with an SS-34 rotor) for 10 min. The resulting supernatant was centrifuged at 10 000 g for 15 min. The resulting pellet was resuspended in 1 ml of stabilization buffer [50 mM Tris-maleate, pH 6.5, 10 % (v\v) glycerol, 0.1 M KCl, 10 mM MgCl # and 0.5 % (v\v) Triton X-100] using 15 strokes of a Dounce A homogenizer. The mitochondrial fraction was used for the assay of PA : CTP cytidylyltransferase, PGP synthase, PGP phosphatase and CL synthase activities. In other experiments, homogenates, mitochondrial fractions and microsomal fractions were prepared as described for the assay of PLA # activity towards ["%C]PG [30] . Marker enzyme analysis indicated that the microsomal fraction was contaminated by approximately 10 % with mitochondrial particles.
Assay of enzymes and other procedures
CL synthase was assayed as described by Schlame and Hostetler [31] . PA : CTP cytidylyltransferase was assayed by the method of Carman and Kelley [32] . PGP synthase was assayed by the method of Carman and Belunis [33] . PGP phosphatase was assayed by the method of MacDonald and McMurray [24] . DNA and RNA synthesis were determined in cells by addition of
thymidine (20 µCi\dish) to cells that were incubated for 4 h in the absence or presence of 30 µM C # -Cer. After labelling, the radioactivity incorporated into DNA and RNA was determined as described [34] . PLA # activity towards ["%C]PG was determined as described in [30] .
Student's t-test was used for the determination of significance ; the level of significance was defined as P 0.05.
RESULTS
Short-chain ceramides stimulate PG and CL biosynthesis in H9c2 cells
To determine whether short-chain ceramides modulate PG and CL metabolism, H9c2 cells were incubated for up to 4 h with [1,3-$H]glycerol in the absence or presence of 30 µM C # -Cer or C ' -Cer, and the incorporation of radioactivity into PG and CL was determined. C # -Cer and C ' -Cer stimulated the incorporation of radioactivity into PG and CL at all times, and this was maximal at 4 h (results not shown). Incubation of cells with C ' -Cer for 4 h caused an approx. 2-fold increase in the incorporation of radioactivity into CL and PG compared with controls (Table  1 ). In cells incubated for 4 h with C # -Cer, incorporation of radioactivity into CL and PG was elevated 3.5-fold and 4.2-fold respectively compared with controls. The presence of these short- (Table 1 ). In cells incubated with SMase, the pool size of SM was decreased by 53 %, from 17.2p2.3 to 8.0p0.6 nmol\mg of protein, but the masses of other phospholipids were not affected [35] . Thus treatment of H9c2 cells with short-chain ceramides elevated PG and CL biosynthesis, and C # -Cer was more potent than C ' -Cer.
C 2 -Cer does not affect the CL pool size, synthesis of high-energy nucleotides or DNA synthesis in H9c2 cells
H9c2 cells were incubated for 4 h in the absence or presence of 30 µM C # -Cer, and the phospholipid phosphorus pool sizes of PG and CL were determined. The presence of C # -Cer in the incubation medium did not affect the phospholipid phosphorus pool sizes of CL and PG, or of other phospholipids ( Table 2) .
We next examined whether DNA and RNA synthesis was (Table 3) . Since CL biosynthesis in H9c2 cells may be regulated by CTP levels [34] , we examined whether C # -Cer treatment of H9c2 cells affected levels of high-energy nucleotides. The pool sizes of ATP, CTP, GTP and UTP in H9c2 cells were 3666, 333, 517 and 708 µM respectively, and these were unaltered when cells were incubated with C # -Cer (means of two determinations). Thus alterations in DNA and RNA synthesis or in levels of high-energy nucleotides were not responsible for the elevated de no o synthesis of PG and CL. As seen in Table 4 , there was a 60 % increase (P 0.05) in lysoPG formation in the mitochondrial fraction of C # -Certreated cells compared with controls. In addition, there was a slight (but not significant) increase in the formation of lysoPG in the microsomal fraction of C # -Cer-treated cells. We attribute this to contamination of the mitochondria with microsomal particles. The C # -Cer-mediated increase in mitochondrial PLA # activity in H9c2 cells was time-and concentration-dependent (Figure 2) . 
C 2 -Cer stimulates PGP synthase activity
We examined the mechanism behind the increase in [1,3-$H]glycerol incorporation into PG and CL in C # -Cer-treated cells. The activities of the enzymes of the CDP-DG pathway of PG and CL biosynthesis were examined. H9c2 cells were incubated for 4 h in the absence or presence of 30 µM C # -Cer and mitochondrial fractions were prepared from homogenates. PA : CTP cytidylyltransferase, PGP synthase, PGP phosphatase and CL synthase were assayed in these mitochondrial fractions. Treatment of cells with C # -Cer did not affect PA : CTP cytidylyltransferase, CL synthase or PGP phosphatase activities compared with controls (Table 5 ). In contrast, mitochondrial PGP synthase activity was increased by 53 % in C # -Cer-treated H9c2 cells compared with controls (Table 6 ). Since PGP synthase activity is also localized to microsomes, the enzyme was also assayed in this subcellular fraction. Microsomal PGP synthase activity was also increased, by 55 %, in C # -Cer-treated H9c2 cells compared with controls ; however, this accounted for only 10 % of the total cellular PGP synthase activity (results not shown). The C # -Cer-mediated increase in mitochondrial PGP synthase activity in H9c2 cells was time-and concentration-dependent (Figure 3 ). To determine whether C # -Cer stimulates PGP synthase directly, mitochondrial fractions from control H9c2 cells were prepared and PGP synthase activity was assayed in these fractions in the presence of 0-1000 µM C # -Cer. The presence of C # -Cer did not stimulate PGP synthase activity directly (results not shown). Thus the stimulation of PGP synthase activity by C # -Cer seems to be indirect.
PGP synthase activity in H9c2 cells may be modulated by ceramide-activated protein phosphatase and cAMP-dependent protein kinase (PKA)
Since the stimulation of PGP synthase activity by C # -Cer seemed to be indirect, we examined whether this effect is mediated through protein kinases or protein phosphatases, since ceramides are known to modulate these activities [15, 16] . Cells were incubated in the presence of 30 µM C # -Cer in the absence or presence of 0.1 µM calyculin A or 0.1 µM okadaic acid. Calyculin A and okadaic acid are potent inhibitors of type 1 and type 2A protein phosphatases. The presence of calyculin A or okadaic acid inhibited the C # -Cer-mediated stimulation of PGP synthase (Table 6 ). These data indicate that, in H9c2 cells, PGP [1, 
H]glycerol into CL and PG in H9c2 cells
H9c2 cells were preincubated for 2 h in the absence or presence of 0.1 µM calyculin A, 0.1 µM okadaic acid or 0.5 mM CPT-cAMP, and subsequently incubated with [1,3- 3 H]glycerol (5 µCi/dish) in the absence or presence of 30 µM C 2 -Cer for 4 h. Radioactivity incorporated into CL and PG was then determined. Results are meanspS.D. of four determinations ; *P 0.05 compared with control ; †P 0.05 compared with C 2 -Cer alone. synthase activity may be modulated through a ceramide-activated protein phosphatase(s) which could be inhibited by calyculin A or okadaic acid.
We next examined whether PMA, a potent stimulator of protein kinase C, or CPT-cAMP, a non-hydrolysable cAMP analogue which stimulates PKA, altered PGP synthase activity. Cells were incubated in the absence or presence of 1 µM PMA or 0.5 mM CPT-cAMP. The presence of CPT-cAMP stimulated PGP synthase activity (Table 6) , indicating an apparent stimulation of enzyme activity by the PKA pathway. PMA did not affect enzyme activity (results not shown). Furthermore, the stimulatory effect of CPT-cAMP on PGP synthase activity appeared to be additive to that of C # -Cer (Table 6 ). We then examined if okadaic acid or calyculin A could block, or if CPT-cAMP could augment, the C # -Cer-mediated stimulation of de no o PG and CL biosynthesis. H9c2 cells were preincubated for 2 h with 0.1 µM calyculin A, 0.1 µM okadaic acid or 0.5 mM CPT-cAMP and subsequently incubated for 4 h with [1,3-$H]glycerol in the absence or presence of 30 µM C # -Cer, and the radioactivity incorporated into PG and CL was determined. The presence of C # -Cer stimulated PG and CL biosynthesis, and this was reversed by both okadaic acid and calyculin A (Table 7 ). In addition, CPT-cAMP stimulated PG and CL biosynthesis, and this effect was additive to the stimulatory effect of C # -Cer.
C 2 -Cer stimulates PG synthesis in permeabilized H9c2 cells
Previously we demonstrated that PG could be synthesized from sn-["%C]glycerol 3-phosphate and exogenous CDP-DG in permeabilized rat liver hepatocytes [25] . To provide another model to demonstrate that C # -Cer treatment of H9c2 cells stimulates PGP synthase activity via a ceramide-activated protein phosphatase(s), we preincubated cells in the absence or presence of C # -Cer for 4 h, and then permeabilized the cells with saponin and incubated them for up to 60 min with ["%C]glycerol 3-phosphate and CDP-DG. We subsequently determined the incorporation of radioactivity into PG. In permeabilized cells, incorporation of radioactivity into PG increased with time ( Figure 4) . In cells preincubated with C # -Cer, incorporation of radioactivity into PG was increased compared with controls, and preincubation with okadaic acid attenuated the C # -Cer-mediated increase in PG biosynthesis. In addition, when cells were preincubated with CPT-cAMP and then permeabilized, PG biosynthesis from ["%C]glycerol 3-phosphate was increased compared with controls.
TNFα stimulates mitochondrial PLA 2 and PGP synthase activities
Since addition of C # -Cer to H9c2 cells would mimic the generation of endogenous ceramide, it was important to demonstrate that an inducer of endogenous ceramide had a similar effect to that of C # -Cer in elevating mitochondrial PGP synthase and PLA # activities. Cells were incubated in the absence or presence of 30 nM TNFα for up to 4 h and mitochondrial fractions were prepared. As seen in Table 8 , there was a 53 % increase (P 0.05) in lysoPG formation in the mitochondrial fraction of cells treated with TNFα for 1 h compared with controls. In contrast, cells treated with TNFα for 4 h did not exhibit an increase in lysoPG formation. This was not surprising, since in HL-60 cells the effects TNFα on SM hydrolysis and ceramide generation were shown to be rapid (within 1 h), and by 4 h ceramide and SM levels were shown to have returned to control values [10] . Treatment of cells with TNFα for 1 h resulted in a 47 % elevation in PGP synthase activity, whereas treatment for 4 h did not affect this activity. Thus TNFα addition to H9c2 cells resulted in a stimulation of both mitochondrial PLA # and PGP synthase activities, similar to that produced by C # -Cer. Taken together, all of the above results suggest that, in H9c2 cells, PG and CL metabolism may be regulated by intracellular ceramide signalling.
DISCUSSION
In the present study, the effects of short-chain ceramides on PG and CL biosynthesis in H9c2 cells were investigated. Our results demonstrate that addition of short-chain ceramides to H9c2 cardiac myoblasts resulted in the stimulation of PG and CL biosynthesis, and the mechanism was an increase in mitochondrial PGP synthase activity. The increase in PGP synthase activity, and hence in PG and CL biosynthesis, might be a compensatory mechanism for a ceramide-mediated elevation in mitochondrial PLA # activity, since the pool sizes of PG and CL were unaltered. The results with both intact and permeabilized cells provide evidence that PGP synthase activity in H9c2 cells may be regulated by a mechanism involving a ceramide-activated protein phosphatase(s). To our knowledge this study is the first demonstration that mammalian PGP synthase, and hence PG and CL biosynthesis, may be regulated by intracellular ceramide signalling.
The products of the SMase-catalysed reaction, i.e. ceramide and sphingosine, may be involved in the regulation of protein kinase C activity in cells (for reviews, see [36, 37] ). Our finding that the addition of sphingosine to H9c2 cells did not affect PG and CL metabolism suggests that such metabolism in these cells is not regulated through protein kinase C. A previous study had indicated that PMA induced retinoblastoma gene product phosphorylation in Molt-4 cells and that C ' -Cer inhibited this effect by inhibiting the protein kinase C pathway [38] . The finding that PMA did not affect PGP synthase activity in H9c2 cells suggests that the effect of C # -Cer on this enzyme in these cells is probably not mediated by the protein kinase C pathway. Furthermore, incubation of cells with SMase did not affect PG or CL biosynthesis from [1,3-$H]glycerol or PGP synthase activity, whereas C # -Cer and TNFα were effective in stimulating PGP synthase activity. These data suggest that the pool of ceramide produced from hydrolysis of SM in the outer leaflet of the plasma membrane does not participate in the regulation of PG and CL metabolism. Several studies support the existence of a signal-transducing pool of SM that is distinct from the pool that is accessible to exogenous SMase (for a review, see [8] ). In U987 cells the biological actions of ceramide were shown to depend upon its topology of production [39] . Ceramide generated by membrane-associated neutral SMase activated pathways different from those activated by ceramide generated by endosomal acidic SMase. When Molt-4 leukaemia cells were transfected with Bacillus cereus SMase, the resultant increases in SMase activity and cellular levels of ceramide resulted in cleavage of poly(ADP-ribosyl)polymerase, and hence apoptosis [40] . In contrast, addition of exogenous Bacillus cereus SMase to these cells did not induce such changes. Thus it is likely that the intracellularly generated ceramide pool, but not the ceramide pool generated at the outer leaflet of the plasma membrane, is biologically active for the regulation of PG and CL metabolism in H9c2 cells. The C # -Cer-mediated regulation of PGP synthase is likely to be physiological rather than pharmacological, since C ' -Cer, as well as C # -Cer, was active in stimulating PG and CL biosynthesis in H9c2 cells, and the C # -Cer-mediated stimulation of PG and CL biosynthesis was concentration-dependent. The concentration-dependent effects of short-chain cell-permeant ceramides on cellular metabolic processes are well documented [41, 42] . Furthermore, addition of TNFα to H9c2 cells resulted in stimulation of PGP synthase activity.
Ceramide was shown to directly activate highly purified forms of heterotrimeric protein phosphatase 2A [15] . In H9c2 cells, calyculin A or okadaic acid attenuated the C # -Cer-mediated elevation of PGP synthase activity and of PG and CL biosynthesis. Thus it is likely that PGP synthase activity, and hence PG and CL biosynthesis, in H9c2 cells are modulated by a ceramide-activated protein phosphatase(s). As an alternative hypothesis, the phosphatase inhibitors could target a component of the C # -Cer response pathway that is necessary to initiate the increase in PG and CL labelling, but is not directly related to PGP synthase. This is unlikely, since preincubation with C # -Cer resulted in an elevation of PG biosynthesis from exogenous sn-["%C]glycerol 3-phosphate in permeabilized H9c2 cells, and this could be reversed by preincubation with okadaic acid. Since CL synthase activity was unaltered in H9c2 cells incubated with C # -Cer, it was possible that the elevated de no o synthesis of CL observed was due to an increase in the specific radioactivity of PG. Although we cannot exclude this possibility, newly synthesized PG has been shown to be preferentially utilized for CL biosynthesis [30] . Addition of CPT-cAMP to H9c2 cells stimulated PG and CL biosynthesis from [1,3-$H]glycerol and PGP synthase activity. In addition, preincubation with CPT-cAMP stimulated PG biosynthesis from sn-["%C]glycerol 3-phosphate in permeabilized cells. These two findings implicate PKA as being involved in the regulation of PG and CL biosynthesis. The stimulation of PGP synthase activity and of PG and CL biosynthesis by C # -Cer in combination with CPT-cAMP was additive. A previous study in HEL 299 cells indicated that downregulation of the M # muscarinic receptor is mediated by synergy between activation of both the ceramide and PKA pathways [43] .
Rapid alterations in CL metabolism have been reported previously [44] . In that study, intraperitoneal injection of aged rats with acetylcarnitine resulted in a rapid (within 3 h) elevation of cardiac mitochondrial CL levels. In our study, C # -Cer treatment of H9c2 cardiac cells for 4 h resulted in rapid de no o synthesis of PG and CL, but the pool sizes of these phospholipids were not significantly altered. Since mitochondrial PLA # activity was elevated in H9c2 cells treated with C # -Cer or TNFα, it is likely that the rapid elevation of mitochondrial CL levels in acetylcarnitine-treated aged rats is different from that involved in C # -Cer signalling. In addition, the increase in mitochondrial PLA # activity in C # -Cer-treated cells would explain why we did not observe an accumulation of PG or CL mass that would normally accompany an elevation in PGP synthase activity [45] . Finally, it is possible that the observed increase in mitochondrial phospholipid turnover mediated by C # -Cer or TNFα in H9c2 cells may be the primary event that drives the ceramide-mediated stimulation of PG and CL biosynthesis. Thus the elevation of PGP synthase activity may simply be a compensatory mechanism to maintain the appropriate levels of these glycerophospholipids in the mitochondrial membrane during ceramide generation. A previous study indicated that phospholipid turnover may play an important role in phospholipid regulation in eukaryotic cells [46] . In conclusion, our results support the notion that PG and CL metabolism in H9c2 cells may be regulated by intracellular ceramide signalling.
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